2024-03-12 17:18:28 ET
More on Champions Oncology
Read the full article on Seeking Alpha
For further details see:
Champions Oncology Non-GAAP EPS of -$0.16, revenue of $12M2024-03-12 17:18:28 ET
Read the full article on Seeking Alpha
For further details see:
Champions Oncology Non-GAAP EPS of -$0.16, revenue of $12MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...